How many triptans are there? The role of triptans in migraine therapy;Welche triptane gibt es? Stellenwert der triptane in der migränetherapie

Pharmazie in Unserer Zeit

Volumn 31, Issue 5, 2002, Pages 462-468

  Diener, Hans Christoph ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALMOTRIPTAN; ANTIMIGRAINE AGENT; CAFERGOT; CAFFEINE; DIHYDROERGOTAMINE; ELETRIPTAN; ERGOTAMINE TARTRATE; NARATRIPTAN; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; RIZATRIPTAN; SEROTONIN 1B AGONIST; SEROTONIN 1D AGONIST; SUMATRIPTAN; SUMATRIPTAN SUCCINATE; ZOLMITRIPTAN;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG CONTRAINDICATION; DRUG FORMULATION; DRUG INDUCED DISEASE; HEADACHE; HUMAN; INJECTION; INJECTION SITE; MAJOR CLINICAL STUDY; META ANALYSIS; MIGRAINE; MULTICENTER STUDY; PARESTHESIA; RECURRENT DISEASE; REVIEW; SEROTONINERGIC SYSTEM; SUPPOSITORY; TREATMENT FAILURE;

EID: 0036384792     PISSN: 00483664     EISSN: None     Source Type: Journal    
DOI: 10.1002/1615-1003(200209)31:5<462::aid-pauz462>3.0.co;2-%23     Document Type: Review

References (79)

1. The Subcutaneous Sumatriptan International Study Group. N Engl J Med 1991;325:316-321.
2. Cady RK et al. JAMA 1991;265:2831-2835.
3. Salonen R et al. Cephalalgia 1999;19:16-19.
4. Visser WH, for the Study G. Cephalalgia 1993;13(Suppl. 13):1892-578.
5. Visser WH et al. Clinical Pharmacological Therapy 1996;60:452-460.
6. O'Callaghan J et al. Cephalalgia 1993;13(suppl 13):161.
7. Gross MLP et al. Headache 1995;35:601-606.
8. Tfelt-Hansen P. Cephalalgia 1998;18:532-538.
9. The Oral Sumatriptan Dose-Defining Study Group. Eur Neurol 1991;31:300-305.
10. Pfaffenrath V et al. Headache 1998;38:184-190.
11. Salonen R et al. IJCP 1999;105:16
12. Ferrari MD et al. Cephalalgia 1994;14:330-338.
13. Ashford E et al. Cephalalgia 1998;18:273-277.
14. Ashford E et al. Cephalalgia 1998;18:273-7.
15. Salonen R et al. J Neurol 1994;241:463-469.
16. Klassen AC et al. Poster, VII. IHS Congress, Toronto 1995:640-645.
17. Kunka RL et al. Cephalalgia 1997;17:532-540.
18. Tepper SJ et al. Int J Clin Pract 1998;52:31-35.
19. The Oral Sumatriptan and Aspirin plus Metoclopramide Comparative Study Group. Eur Neurol 1992;32:177-184.
20. Tfelt-Hansen P et al. Lancet 1995;346:923-926.
21. Diener HC, for the ASASUMAMIG Study Group. Cephalalgia 1999;19:581-588.
22. Massiou H, on Behalf of the Study Group. Poster, 3rd European Headache Conference, Sardinia 1996:56-59.
23. Dahlöf C. Cephalalgia 1999;19:769-778.
24. Boureau F et al. Int J Clin Pract 2000;54(5):281-286.
25. The Multinational Oral Sumatriptan Cafergot Comparative Study Group. Eur Neurol 1991;31:314-322.
26. Hämäläinen ML et al. Neurology 1997;48:1100-1103.
27. Überall MA et al. Neurology 1999;52:1507-1510.
28. Visser WH et al. Neurology 1996;46:522-526.
29. Dahlof C et al. Headache 1995;35:2923.
30. Rapoport AM et al. Neurology 1997;49:1210-1218.
31. Solomon GD et al. Neurology 1997;49:1219-1225.
32. Nappi G et al. Rev Contemp Pharmacother 2000;11:99-118.
33. Geraud G et al. Cephalalgia 2000;20:30-38.
34. Diener HC. Proceedings of the 3rd European Headache Conference, Sardinia 1996:10-11.
35. The International 311C90 Long-Term Study Group. Headache 1998;38:173-183.
36. Zagami AS et al. Neurology 1997;48 Suppl 3;S25-S28.
37. Millson D et al. Europ J Neurol 1998;5 (S49).
38. Loder E. Headache Quarterly 1998;9(1):66.
39. Goadsby PJ. J. Neurol. Neurosurg. Psychiatry 1998;64:143-147.
40. Dahlöf C et al. Europ J Neurol 1998;5:469-477.
41. Salonen R. Int J Clin Pract 1999;53:552-556.
42. Goadsby PJ. Cephalalgia 1997;17:472-473.
43. Klassen A et al. Headache 1997;37:630-645.
44. Mathew NT et al. on behalf of the Naratriptan S2WA3001 Study Group. Neurology 1997;49:1485-1490.
45. Tfelt-Hansen P et al. Neurology 1999;52:1300-1310.
46. Göbel H et al. Poster, VIIIth IHS Congress, Amsterdam 1997:163-165.
47. Stark S et al. Headache 2000;40:513-520.
48. Gijsman H et al. Cephalalgia 1997;17:647-651.
49. Teall J et al. Headache 1998;38:281-287.
50. Kramer MS et al. Neurology 1998;51:773-781.
51. Tfelt-Hansen P et al. Headache 1998;38:748-755.
52. Goldstein J et al. Headache 1998;38:737-747.
53. Tfelt-Hansen P et al. Neurology 2000;55 (Suppl. 2):S19-S24.
54. Pascual J et al. Cephalalgia 2000;20:455-461.
55. Bomhof M et al. Eur Neurol 1999;42:173-179.
56. Goadsby PI. Cephalalgia 2000;20 (Suppl. 1):10-15.
57. Ahrens SP et al. Cephalalgia 1999;19:525-530.
58. Adelman JU et al. Headache 2000;40:371-372.
59. Cabarrocas X, Zayas JM, on behalf of the Almotriptan Oral Study Group. Headache 1998;38:377.
60. Pascual J. Therapy with other triptans: almotriptan. In: Diener HC, editor. Drug treatment of migraine and other headaches. Basel: Karger; 2000. p. 197-205.
61. Pascual J et al. Cephalalgia 2000;20:588-596.
62. Cabarrocas X et al. Headache 1998;38:377-378.
63. Färkkilä M et al. on behalf of the Eletriptan Steering Committee. Cephalalgia 1996;16:387.
64. Goadsby PJ et al. Neurology 2000;54:156-163.
65. Steiner TJ, on behalf of the Eletriptan Steering Committee. Migraine Trust, London 1998.
66. MacGregor EA. In: 50th Meeting of the American Academy of Neurology; 1998; Minneapolis; 1998.
67. Pryse-Philips W, on behalf of the Eletriptan Steering Committee. 9th Congress of the International Headache Society 1999.
68. Reeches A, on behalf of the Eletriptan Steering Committee. In: 9th Congress of the International Headache Society; 1999; Barcelona; 1999.
69. Diener HC. In: Diener HC, editor. Drug treatment of migraine and other headaches. Basel: Karger; 2000. p. 184-189.
70. Ferrari MD. In: Olesen J, Ferrari MD, Humphrey PPA, editors. The Triptans: Novel Drugs in Migraine. Oxford: Oxford University Press; 2001. p. in press.
71. Ferrari MD et al. Lancet 2001; 358: 1668-1675.
72. Goadsby et al. N Engl J Med 2002; 346: 257-270.
73. Visser WH et al. Cephalalgia 1996; 16: 264-269.
74. Kaube H et al. BMJ 1994;308:1573.
75. Evers S et al. Clin Neuropharmacol 1999;22:201-206.
76. Limmroth V et al. Lancet 1999;353:378.
77. Dahlöf CGH et al. Cephalalgia 1998;18:539-545.
78. Welch KMA et al. Cephalalgia 2000;20:687-695.
79. MaassenVanDenBrink A et al. Circulation 1998;98:25-30.